| PPBT |
Purple Biotech Ltd. |
Ordinary shares, no par value per share |
9.99% |
$115M |
$34.9M |
200M |
+43.6% |
Mitchell P. Kopin |
Sep 30, 2025 |
| LGVN |
Longeveron Inc. |
Class A Common Stock, par value $0.001 per share |
9.99% |
$1.78M |
|
2.14M |
|
Mitchell P. Kopin |
Aug 8, 2025 |
| ICU |
SeaStar Medical Holding Corporation |
Common stock, par value $0.0001 per share |
9.99% |
$1.77M |
$738K |
3.1M |
+71.8% |
Mitchell P. Kopin |
Sep 30, 2025 |
| GOVX |
GeoVax Labs, Inc. |
Common stock, par value $0.001 per share |
9.99% |
$1.35M |
$27K |
2.85M |
+2.04% |
Mitchell P. Kopin |
Sep 30, 2025 |
| SILO |
Silo Pharma, Inc. |
Common stock, par value $0.0001 per share |
9.99% |
$1.04M |
$410K |
1.38M |
+65.2% |
Mitchell P. Kopin |
Sep 30, 2025 |
| LUCY |
Innovative Eyewear, Inc. |
Common stock, par value $0.00001 per share |
9.99% |
$1.03M |
$65K |
508K |
+6.73% |
Mitchell P. Kopin |
Sep 30, 2025 |
| ASNS |
ACTELIS NETWORKS INC |
Common stock, par value $0.0001 per share |
9.99% |
$757K |
$757K |
1.94M |
|
Mitchell P. Kopin |
Nov 7, 2025 |
| SBFM |
Sunshine Biopharma Inc. |
Common stock, par value $0.001 per share |
9.99% |
$703K |
|
506K |
|
Mitchell P. Kopin |
May 19, 2025 |
| ASTI |
Ascent Solar Technologies, Inc. |
Common stock, par value $0.0001 per share |
9.99% |
$663K |
$40K |
338K |
+6.43% |
Mitchell P. Kopin |
Sep 30, 2025 |
| PCSA |
Processa Pharmaceuticals, Inc. |
Common stock, par value $0.0001 per share |
9.99% |
$596K |
-$22.8K |
2.91M |
-3.68% |
Mitchell P. Kopin |
Jun 30, 2025 |
| BBLG |
Bone Biologics Corporation |
Common stock, par value $0.001 per share |
9.99% |
$482K |
$111K |
199K |
+30% |
Mitchell P. Kopin |
Sep 30, 2025 |
| APDN |
Applied DNA Sciences, Inc. |
Common Stock, par value $0.001 per share |
9.99% |
$457K |
|
143K |
|
Mitchell P. Kopin |
Jul 8, 2025 |
| BJDX |
Bluejay Diagnostics, Inc. |
Common Stock, par value $0.0001 per share |
9.99% |
$273K |
|
178K |
|
Mitchell P. Kopin |
Oct 10, 2025 |
| SXTP |
60 Degrees Pharmaceuticals, Inc. |
Common stock, par value $0.0001 per share |
9.99% |
$205K |
$37.4K |
456K |
+22.3% |
Mitchell P. Kopin |
Sep 30, 2025 |
| CETX |
Cemtrex Inc. |
Common stock, par value $0.001 per share |
9.99% |
$33.6K |
-$104K |
82K |
-75.6% |
Mitchell P. Kopin |
Sep 30, 2025 |
|
PharmaCyte Biotech, Inc. |
Common Stock, $0.0001 par value per share |
9.99% |
|
|
696K |
-2.68% |
Mitchell P. Kopin |
Sep 30, 2025 |
|
Silexion Therapeutics Corp |
Ordinary shares, par value $0.0135 per share |
9.99% |
|
|
245K |
|
Mitchell P. Kopin |
Sep 11, 2025 |
| NCPL |
Netcapital Inc. |
Common stock, par value $0.001 per share |
9.3% |
$1.19M |
$509K |
502K |
+74.3% |
Mitchell P. Kopin |
Sep 30, 2025 |
|
Aethlon Medical, Inc. |
Common Stock, par value $0.001 per share |
7.7% |
|
|
577K |
|
Mitchell P. Kopin |
Sep 4, 2025 |
| PHIO |
Phio Pharmaceuticals Corp. |
Common stock, par value $0.0001 per share |
7% |
$1.01M |
-$236K |
430K |
-18.9% |
Mitchell P. Kopin |
Sep 30, 2025 |
| NAYA |
NAYA Biosciences Inc. |
Common stock, par value $0.0001 per share |
6.9% |
$166K |
|
504K |
|
Mitchell P. Kopin |
Jan 12, 2025 |
| SVRE |
SaverOne 2014 Ltd. |
Ordinary shares, par value NIS 0.01 per share |
4.99% |
$11.3M |
|
35.5M |
|
Mitchell P. Kopin |
Jan 30, 2025 |
| BLRX |
BioLineRx Ltd. |
Ordinary shares, par value NIS 0.10 per share |
4.99% |
$11.2M |
|
102M |
|
Mitchell P. Kopin |
Jan 6, 2025 |
| BNGO |
Bionano Genomics, Inc. |
Common Stock, par value $0.0001 per share |
4.99% |
$1.96M |
|
508K |
|
Mitchell P. Kopin |
Sep 16, 2025 |
| DPRO |
Draganfly Inc. |
Common shares, no par value per share |
4.99% |
$1.84M |
$595K |
990K |
+47.8% |
Mitchell P. Kopin |
Jul 17, 2025 |
| SNGX |
Soligenix, Inc. |
Common Stock, par value $0.001 per share |
4.99% |
$1.24M |
|
446K |
|
Mitchell P. Kopin |
Sep 25, 2025 |
| BCDA |
BioCardia, Inc. |
Common Stock, par value $0.001 per share |
4.99% |
$1.09M |
|
557K |
|
Mitchell P. Kopin |
Sep 18, 2025 |
| JZXN |
Jiuzi Holdings Inc. |
Ordinary shares, par value $0.00039 per share |
4.99% |
$1.08M |
|
1.06M |
|
Mitchell P. Kopin |
Sep 29, 2025 |
| IMNN |
Imunon, Inc. |
Common stock, par value $0.01 per share |
4.99% |
$854K |
-$35.1K |
1.07M |
-3.95% |
Mitchell P. Kopin |
Jun 30, 2025 |
| JAGX |
Jaguar Health, Inc. |
Common stock, par value $0.0001 per share |
4.99% |
$779K |
|
65K |
|
Mitchell P. Kopin |
May 20, 2025 |
| SLRX |
Salarius Pharmaceuticals, Inc. |
Common Stock, par value $0.0001 per share |
4.99% |
$712K |
|
187K |
|
Mitchell P. Kopin |
Nov 12, 2025 |
| VVOS |
Vivos Therapeutics Inc. |
Common stock, par value $0.0001 per share |
4.99% |
$708K |
|
297K |
|
Mitchell P. Kopin |
Dec 22, 2024 |
| KTTA |
Pasithea Therapeutics Corp. |
Common stock, par value $0.0001 per share |
4.99% |
$451K |
|
318K |
|
Mitchell P. Kopin |
May 6, 2025 |
| GXAI |
Gaxos.ai Inc. |
Common stock, par value $0.0001 per share |
4.99% |
$393K |
$76.4K |
364K |
+24.1% |
Mitchell P. Kopin |
Dec 26, 2024 |
| VERO |
Venus Concept Inc. |
Common stock, par value $0.0001 per share |
4.99% |
$300K |
$206K |
120K |
+219% |
Mitchell P. Kopin |
Jun 6, 2025 |
| NUWE |
Nuwellis, Inc. |
Common stock, par value $0.0001 per share |
4.99% |
$251K |
|
251K |
|
Mitchell P. Kopin |
Jun 9, 2025 |
| MBIO |
Mustang Bio, Inc |
Common stock, par value $0.0001 per share |
4.99% |
$178K |
-$48.8K |
186K |
-21.5% |
Mitchell P. Kopin |
Jun 30, 2025 |
| SLXN |
Silexion Therapeutics Corp |
Ordinary shares, par value $0.0009 per share |
4.99% |
$172K |
|
210K |
|
Mitchell P. Kopin |
Jan 15, 2025 |
| LIXT |
Lixte Biotechnology Holdings, Inc. |
Common stock, par value $0.0001 per share |
4.99% |
$168K |
|
139K |
|
Mitchell P. Kopin |
Feb 11, 2025 |
| ATNF |
180 Life Sciences Corp. |
Common stock, par value $0.0001 per share |
4.99% |
$117K |
|
165K |
|
Mitchell P. Kopin |
Dec 27, 2024 |
| NAYA |
INVO Fertility, Inc. |
Common stock, par value $0.0001 per share |
4.99% |
$72.4K |
|
35K |
|
Mitchell P. Kopin |
Mar 31, 2025 |
| GRI |
GRI Bio, Inc. |
Common stock, par value $0.0001 per share |
4.99% |
$53.5K |
|
40.3K |
|
Mitchell P. Kopin |
Apr 1, 2025 |
|
Cellectar Biosciences, Inc. |
Common stock, par value $0.00001 per share |
4.99% |
|
|
140K |
|
Mitchell P. Kopin |
Jul 1, 2025 |
|
Genprex, Inc. |
Common Stock, par value $0.001 per share |
4.99% |
|
|
84.8K |
|
Mitchell P. Kopin |
Oct 28, 2025 |
| LFWD |
Lifeward Ltd. |
Ordinary Shares, par value NIS 1.75 per share |
4.99% |
|
|
819K |
+48% |
Mitchell P. Kopin |
Jun 25, 2025 |
|
DEFSEC Technologies Inc. |
Common shares, no par value per share |
4.99% |
|
|
71.7K |
|
Mitchell P. Kopin |
Jul 23, 2025 |
| AREB |
American Rebel Holdings, Inc. |
Common stock, par value $0.001 per share |
4.7% |
$423K |
$246K |
336K |
+139% |
Mitchell P. Kopin |
Jun 30, 2025 |
| ADD |
Zeta Network Group |
Class A Ordinary Shares, par value $0.0001 per share |
3.7% |
$76.6K |
-$31.7K |
1.09M |
-29.3% |
Mitchell P. Kopin |
Aug 13, 2025 |
| ADIL |
Adial Pharmaceuticals, Inc. |
Common stock, par value $0.001 per share |
2.8% |
$281K |
|
446K |
|
Mitchell P. Kopin |
Jun 17, 2025 |
| LMFA |
LM Funding America, Inc. |
Common Stock, par value $0.001 per share |
2.7% |
$527K |
|
405K |
|
Mitchell P. Kopin |
Aug 18, 2025 |
| ENVB |
Enveric Biosciences, Inc. |
Common Stock, par value $0.01 per share |
0.4% |
$28K |
-$123K |
19.3K |
-81.4% |
Mitchell P. Kopin |
Sep 18, 2025 |
| DRMA |
Dermata Therapeutics, Inc. |
Common stock, par value $0.0001 per share |
0.4% |
$18.9K |
-$194K |
23.3K |
-91.1% |
Mitchell P. Kopin |
Mar 31, 2025 |
| DATS |
DatChat, Inc. |
Common stock, par value $0.0001 per share |
0% |
$0 |
|
0 |
|
Mitchell P. Kopin |
Jan 8, 2025 |
| MBOT |
Microbot Medical Inc. |
Common stock, par value $0.01 per share |
0% |
$0 |
-$12.8M |
0 |
-100% |
Mitchell P. Kopin |
Sep 30, 2025 |
| SLNH |
Soluna Holdings, Inc. |
Common stock, par value $0.001 per share |
0% |
$0 |
-$7.04M |
0 |
-100% |
Mitchell P. Kopin |
Sep 30, 2025 |
| APVO |
Aptevo Therapeutics Inc. |
Common stock, par value $0.001 per share |
0% |
$0 |
|
0 |
|
Mitchell P. Kopin |
Jun 18, 2025 |